T0	Participants 0 110	Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog:
T1	Participants 218 270	short children born small for gestational age (SGA).
T2	Participants 765 776	expectation
T3	Participants 859 921	included 121 short SGA children (60 boys) at least 8 yr of age
T4	Participants 926 1038	performed intention-to-treat analyses on all children and uncensored case analyses on 84 children who reached AH
T5	Participants 1225 1251	RESULTS Short SGA children
T6	Participants 1913 1985	in short SGA children, particularly with GH 2 mg/m(2) Â· d during puberty